Former U.S. President Bill Clinton and drugmakers Pfizer and Matrix Laboratories Ltd announced a deal on Thursday to lower the cost of treatments for patients with drug-resistant forms of HIV/AIDS.
Second-line antiretroviral therapies and a drug used to treat tuberculosis for those with drug-resistant HIV/AIDS will be made available at a reduced cost and in more convenient regimens, saving as many as hundreds of thousands of lives in the developing world.
President-elect Donald Trump's choice to run the sprawling government agency that administers Medicare, Medicaid, and the...
Higher usage of personal care products among pregnant or nursing women leads to higher levels of...
